Some members of Congress are calling for an investigatation of the abrupt resignation of Lester M. Crawford, DVM, as commissioner of the Food and Drug Administration. Crawford resigned on September 23, serving only 2 months after his confirmation. He had been the acting head of the Food and Drug Administration since 2002.
In the week following Crawford’s resignation, some members of Congress asked the inspector general of the Department of Health and Human Services (HHS) to examine whether Crawford’s financial reporting had complied with various ethics laws. Newspaper accounts said Crawford had failed to reveal all of his financial information to the Senate prior to confirmation hearings earlier this year.
Mitka M. Resignation Inquiry. JAMA. 2005;294(18):2292. doi:https://doi.org/10.1001/jama.294.18.2292-c
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: